Workflow
Cosmetics & Personal Care
icon
Search documents
Naturium Debuts First-Ever Pop-Up in Los Angeles, Bringing Biocompatible Skincare to Every One, Every Where, Every Day
Businesswire· 2025-10-03 04:01
Core Insights - Naturium launches its first-ever pop-up event, The Consistency Club on Tour, in Los Angeles, promoting its new brand campaign, "Every One, Every Where, Every Day" [1][2][3] Event Details - The Consistency Club on Tour is a three-day community-driven roadshow aimed at celebrating consistent skincare through immersive experiences [2][4] - The event features interactive stations, gamified touchpoints, and hands-on testing, allowing visitors to discover their ideal skincare regimen [4][6] - Tour dates include October 3 at The Brig, October 4 at Sportsman's Lodge, and October 5 at Melrose Farmer's Market [7] Brand Philosophy - Naturium emphasizes the importance of community and consistency in skincare, as articulated by founder Susan Yara [5][6] - The brand's philosophy is reflected in the event's design, which aims to create a fun and engaging environment for skincare education and connection [5][6] Product Highlights - The pop-up will spotlight Naturium's key products, including Glow Getter Multi-Oil Body Wash, Vitamin C Complex Serum, and Multi-Peptide Advanced Serum [7] - Attendees will have access to personalized consultations for skin analysis and routine-building experiences [7] Company Background - Founded in 2019 by Susan Yara, Naturium focuses on biocompatible and dermatologist-tested skincare products that blend natural botanicals with potent actives [8] - The brand was acquired by e.l.f. Beauty in 2023 and is available online and in stores at Target and Ulta in the U.S. [8]
Coty initiates strategic review of consumer beauty business
Yahoo Finance· 2025-10-01 08:18
Core Insights - Coty is conducting a strategic review of its consumer beauty segment to "unleash its full potential" focusing on its $1.2 billion mass colour cosmetics business and its Brazilian operations generating close to $400 million in revenue [1][2] Strategic Review - The review will explore various options including partnerships, divestitures, spin-offs, and other strategic actions to maximize long-term value and strengthen the balance sheet [2] - Coty plans to integrate its Prestige Beauty and Mass Fragrance businesses more closely, emphasizing its heritage and core strengths [2][3] Organizational Changes - The company aims to drive organizational changes for closer integration and coordination between prestige and consumer beauty fragrances, which currently account for 69% of Coty's sales [3] - The new structure will leverage Coty's scale in research and development, consumer insights, manufacturing, and distribution [3] Leadership and Management - CEO Sue Nabi highlighted that integrating fragrance brands will unlock the full potential of Coty's scale, as the fragrance category outperforms the global beauty market [4] - Gordon von Bretten has been appointed as president of consumer beauty, responsible for delivering the potential of mass cosmetics and personal care brands, and will lead the strategic review [5][6] Future Focus - The agenda includes realizing the full potential of market-leading brands by focusing the portfolio, enhancing product excellence, and driving productivity for visible growth, margin expansion, and cash generation [6] - Coty's prestige division will continue to expand its cosmetics and skincare offerings [4]
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Coty Inc. – COTY
Globenewswire· 2025-09-24 14:44
Core Viewpoint - Pomerantz LLP is investigating potential securities fraud and unlawful business practices involving Coty Inc. and its executives following disappointing financial results and guidance [1][3]. Financial Performance - On August 20, 2025, Coty reported an unexpected loss for its full fiscal year 2025 and fourth quarter, which was attributed to challenges in the beauty market, including consumer behavior and policy changes [3]. - The Chief Financial Officer of Coty indicated that sluggish sales were due to value-seeking behavior, innovation fatigue among consumers, and changes in anti-theft and immigration policies [3]. Stock Market Reaction - Following the announcement of the financial results, Coty's stock price dropped by $1.05 per share, representing a decline of 21.6%, closing at $3.81 per share on August 21, 2025 [4].
Jim Cramer on e.l.f.: “I Think We Have to Wait Till it Comes Down”
Yahoo Finance· 2025-09-19 03:52
Group 1 - e.l.f. Beauty, Inc. (NYSE:ELF) has experienced a significant surge in stock value, prompting discussions about its investment potential and associated risks, particularly concerning China [1][2] - The company develops and markets a range of cosmetics and skincare products under various brands, including e.l.f. Cosmetics and e.l.f. Skin [2] - Concerns were raised about the stock's recent parabolic move, with suggestions to consider trimming positions rather than buying more at this time [1] Group 2 - While e.l.f. Beauty is recognized for its investment potential, there are opinions that certain AI stocks may offer greater upside potential with less downside risk [3] - The article hints at the possibility of undervalued AI stocks benefiting from current market trends, suggesting a shift in focus for investors [3]
Did Coty Overload Retailers to Mask Inventory Issues? Investigation Seeks to Answer the Question -- Hagens Berman
Prnewswire· 2025-09-17 01:36
Core Insights - Hagens Berman is investigating Coty Inc. following a 21% drop in its stock price due to "retailer inventory destocking issues" and weak financial results for Q4 and the full year [1][4]. Group 1: Investigation Details - The investigation focuses on whether Coty misled investors regarding its growth and the effectiveness of its digital inventory strategy, SAP S/4HANA [2][5]. - There are concerns that Coty may have shipped excess inventory to retail partners to obscure its own inventory buildup, which could mislead investors about its financial health [3][5]. Group 2: Financial Performance - The August 21 earnings report indicated a significant year-over-year revenue decline in Coty's Prestige and Consumer Beauty segments, which account for approximately 65% and 35% of total revenue, respectively [4]. - The company attributed its poor performance partly to retailer inventory issues that it had previously minimized [4]. Group 3: Legal and Investor Actions - Hagens Berman is urging investors who have suffered losses to come forward and assist in the investigation [2][6]. - The firm has a history of representing investors and has secured over $2.9 billion in similar cases [7].
COTY SECURITIES NOTICE: Did Coty Inc. Mislead Investors? Contact BFA Law if You Lost Money on Your Investment
Globenewswire· 2025-09-12 12:18
Core Viewpoint - Coty Inc. is under investigation for potential violations of federal securities laws, following disappointing financial results and claims of overstated demand for its Prestige fragrances [1][2][3]. Group 1: Company Overview - Coty Inc. is one of the largest beauty companies globally, with a diverse portfolio that includes fragrance, color cosmetics, and skin and body care products [2]. - Prestige fragrances represent 60% of Coty's revenues, indicating a significant reliance on this segment [2]. Group 2: Financial Performance - On August 20, 2025, Coty reported disappointing financial results for Q4 and FY 2025, citing issues such as weaknesses in U.S. execution and retailer inventory buildup [3]. - The company's stock price fell by $1.05, a decline of over 21%, from $4.86 to $3.81 per share following the announcement of these results [3]. Group 3: Market Dynamics - Coty indicated that the slowdown in cosmetics sales was influenced by value-seeking consumer behavior, fatigue with innovation, and specific U.S. factors such as in-store security measures and immigration policy changes [3].
COTY ALERT: Bragar Eagel & Squire, P.C. is Investigating Coty Inc. on Behalf of Coty Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire News Room· 2025-08-31 12:23
Core Insights - Coty Inc. is under investigation for potential violations of federal securities laws and unlawful business practices following disappointing financial results for fiscal year 2025 [2][3] - The company reported an unexpected loss and provided poor guidance, attributing sluggish sales to various market challenges [3] - Following the announcement, Coty's stock price dropped by $1.05, or 21.6%, closing at $3.81 per share [4] Financial Performance - Coty reported its full fiscal year 2025 and fourth-quarter results on August 20, 2025, highlighting an unexpected loss [3] - The Chief Financial Officer indicated that the challenges faced in fiscal year 2025 were linked to a broader decline in profit within the beauty market [3] Market Reaction - The announcement of the financial results led to a significant decline in Coty's stock price, reflecting investor concerns [4]
Coty Reports Q4 Loss, LFL Revenues Decline Y/Y, Stock Down 18%
ZACKS· 2025-08-21 16:56
Core Insights - Coty Inc. reported fourth-quarter fiscal 2025 results with net revenues of $1,252.4 million, an 8% decline year-over-year, and an adjusted loss of 5 cents per share, missing the Zacks Consensus Estimate of adjusted earnings of 1 cent [1][3][4] Financial Performance - The adjusted gross margin was 62.3%, down 190 basis points from the previous year, reflecting a normalization from elevated levels [5] - Adjusted operating income was $67.7 million, a 37% decline year-over-year, with an adjusted operating margin of 5.4%, down 250 basis points [6] - Adjusted EBITDA decreased 23% year-over-year to $126.7 million, with an adjusted EBITDA margin of 10.1%, down 200 basis points [7] Segment Performance - Prestige segment net revenues were $760.6 million, a 5% decline, with a 7% decline on a like-for-like basis, primarily due to underperformance in the U.S. market [8][10] - Consumer Beauty segment net revenues amounted to $491.8 million, a 12% decline on both reported and like-for-like basis, driven by weakness in color cosmetics and body care categories [12][13] Regional Revenue Results - Americas segment reported net revenues of $511.2 million, a 12% decline, with a 10% decline on a like-for-like basis, mainly due to lower Prestige revenues [15] - EMEA segment generated net revenues of $574.2 million, a 4% decline, with a 9% decline on a like-for-like basis [16] - Asia Pacific segment reported net revenues of $167 million, an 8% decline, with a 9% decline on a like-for-like basis, although sell-out in most markets grew significantly [17] Future Outlook - Coty is entering fiscal 2026 with a focus on innovation and expansion, expecting gradual improvement in sales trends, with like-for-like sales forecasted to decline 6-8% in the first quarter and 3-5% in the second quarter [20][21] - The company anticipates a return to adjusted EBITDA growth in the second half of fiscal 2026, supported by multiple product launches and geographic expansion [23]
Estee Lauder Q4 Earnings Beat Estimates, Sales Down 12% Y/Y
ZACKS· 2025-08-20 17:01
Core Insights - The Estee Lauder Companies Inc. reported fourth-quarter fiscal 2025 results, with both net sales and earnings declining year over year, despite beating the Zacks Consensus Estimate for adjusted earnings and net sales [1][2]. Financial Performance - Adjusted earnings were 9 cents per share, surpassing the Zacks Consensus Estimate of 8 cents, but down 85% from 64 cents in the same quarter last year [1]. - Quarterly net sales reached $3,411 million, exceeding the Zacks Consensus Estimate of $3,402 million, but reflecting a 12% decline year over year [2]. Category-Wise Revenue Results - Skin Care sales decreased 16% year over year to $1,705 million, primarily due to challenges in the Asia travel retail business [3]. - Makeup revenues fell 11% to $982 million, driven by lower sales from Estee Lauder and M·A·C, as well as reduced sales for Too Faced in North America [4]. - Fragrance category revenues increased 4% to $560 million, led by luxury brands Le Labo and Jo Malone [5]. - Hair Care sales totaled $141 million, down 15% year over year, largely due to challenges in North America [6]. Regional Revenue Results - Sales in the Americas declined 6% year over year to $949 million [7]. - Revenues in the EMEA region fell 22% to $1,293 million [7]. - Asia-Pacific region sales tumbled 3% to $1,166 million [7]. Margin and Operating Performance - Adjusted gross margin improved by 10 basis points year over year to 71.9%, aided by the Profit Recovery and Growth Plan [8]. - The company reported an operating loss of $390 million, compared to a loss of $233 million in the prior year [9]. - Adjusted Operating Income declined 61% to $137 million [9]. Financial Health Snapshot - The company exited the quarter with cash and cash equivalents of $2,921 million, long-term debt of $7,314 million, and total equity of $3,865 million [10]. - Net cash flow from operating activities for the 12 months ended June 30, 2025, was $1,272 million, with capital expenditures of $602 million [10]. Restructuring Program - The company announced an expansion of its Profit Recovery and Growth Plan (PRGP), with a comprehensive restructuring initiative expected to be completed by fiscal 2027 [12]. - Anticipated restructuring charges range from $1.2 billion to $1.6 billion before taxes, with expected annual gross benefits of $800 million to $1 billion [13]. Future Outlook - For fiscal 2026, reported net sales are estimated to rise 2-5%, with adjusted organic net sales expected to grow 0-3% [14]. - Adjusted earnings per share are projected to increase by 26-39%, ranging from $1.90 to $2.10 [14]. - The company expects organic net sales for the first quarter of fiscal 2026 to show a low-single-digit decline to slightly positive growth [15].
SkinMedica® Unveils Its Newest Hydration Hero
Prnewswire· 2025-08-19 12:00
Core Viewpoint - Allergan Aesthetics, a subsidiary of AbbVie, has launched the HA5® Hydra Collagen Hydrating Foaming Cleanser, which is designed to provide hydration and thorough cleansing for the skin, enhancing the effectiveness of subsequent skincare products [1][2]. Product Overview - The HA5® Hydra Collagen Hydrating Foaming Cleanser features the proprietary HA5® Hydra Collagen Complex, which includes five forms of hyaluronic acid and vegan hydra collagen, aimed at delivering instant hydration [1][2]. - The cleanser is formulated with 100% naturally derived amino acid-based surfactants and Pea Peptides, making it suitable for dry and sensitive skin [2]. - Clinical studies indicate that the cleanser can effectively remove makeup and impurities while boosting skin hydration by 30% when used with the HA5® Hydra Collagen Replenish + Restore Hydrator [2][3]. Market Positioning - Allergan Aesthetics emphasizes innovation in aesthetic medicine, positioning the HA5® line as a benchmark for advanced skin hydration solutions [2]. - The new cleanser is part of a broader portfolio that includes products from SkinMedica®, SKINVIVE by JUVÉDERM®, and DiamondGlow®, all aimed at providing superior hydration [2]. Expert Endorsement - Dr. Tiffany J. Libby, a board-certified dermatologist, endorses the product, highlighting its dual function of cleansing and hydrating while respecting the skin barrier [3]. Pricing and Availability - The HA5® Hydra Collagen Hydrating Foaming Cleanser is priced at $48 and is available for purchase on SkinMedica.com [3].